Astrazeneca Pharma India's Stock Reaches All-Time High, Outperforms Sector by 10.63%
Astrazeneca Pharma India, a midcap pharmaceutical company, has seen a surge in its stock price, reaching an all-time high of Rs 8021.2 on September 30, 2024. The stock is currently rated as 'Hold' by MarketsMojo, but has outperformed the sector by 10.63%. Its strong performance and trend reversal make it a promising company in the pharmaceutical industry.
Astrazeneca Pharma India, a midcap pharmaceutical company, has been making headlines in the stock market as its share price reached an all-time high on September 30, 2024. The company's stock has been performing well, with a current price of Rs 8021.2, which is only 1.34% away from its 52-week high.
According to MarketsMOJO, a leading stock market analysis platform, the stock is currently rated as 'Hold'. However, the company's performance today has outperformed the sector by 10.63%, indicating a positive trend. The stock has also shown a trend reversal, gaining after three consecutive days of fall.
Intraday trading saw Astrazeneca Pharma India's stock reach a high of Rs 7959.95, a significant increase of 10.78%. The company's stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong performance.
In comparison to the Sensex, Astrazeneca Pharma India has shown a remarkable 1-year performance of 78.20%, while the Sensex has only grown by 28.11%. This showcases the company's strong growth and potential in the pharmaceutical industry.
With its consistent performance and positive outlook, Astrazeneca Pharma India is definitely a company to watch out for in the midcap segment. Investors can keep an eye on its stock as it continues to make strides in the pharmaceutical and drugs industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
